Adult Immunization
Latest News
Jul 08, 2026 | News
FDA Clears OTC Adapalene-Benzoyl Peroxide Gel for Acne in Patients 12 and Older
How Primary Care Can Close DKA Monitoring Gaps Before Hospitalization
Jul 07, 2026
Why DKA Detection Needs to Start Before the Emergency Department
Jul 07, 2026
FDA Clears First Generic Baloxavir for Influenza Treatment, Postexposure Prophylaxis
Jul 07, 2026
Primary Care–Initiated CGM Linked to Better Diabetes Outcomes, Lower Acute Care Use
Jul 06, 2026
Advertisement
Shorts
0:25
Where Baxdrostat Fits in the Hypertension Treatment Pathway
7 days ago
by
Payal Kohli, MD, FACC
0:38
The Hidden Risk: Pregnancy-Related Deaths After Birth
8 days ago
by
David Goodman, PhD
1:37
Why Baxdrostat is the GOAT of Blood Pressure Medications
9 days ago
by
Payal Kohli, MD, FACC
1:05
Why PCPs Should Feel More Confident Treating Menopause Symptoms
10 days ago
by
Jill Liss, MD
0:36
A Vicious Cycle: How Sleep and Dementia Connect
13 days ago
by
Bryce Mander, PhD
1:06
Why One Specialist Wants Clinicians to Prioritize Sleep in Patient Discussions
14 days ago
by
Michael Grandner, PhD
0:55
Why Sleep Apnea is Often Misdiagnosed in Women
15 days ago
by
Bryce Mander, PhD
0:42
40% of Adults Now Track Sleep With Wearables, But Clinical Use of Data Lags
16 days ago
by
Leanne Kaye, PhD, MPH
0:45
5 Colorectal Cancer Warning Signs to Watch For
a month ago
by
Xavier Llor, MD, PhD
0:43
Why Hypertension Treatment is Failing Half of Patients
a month ago
by
Payal Kohli, MD, FACC
Nephrology Condition Center Quiz
As a part of efforts to develop further educational resources on chronic kidney disease (CKD) we are asking you to take this short quiz. From your response we will be able to see where there are gaps in knowledge and we can work to fill those gaps.
Exclusive Survey Results: Screening For Cognitive Decline in Primary Care
New survey finds that most PCPs screen for mild cognitive impairment, but time is an issue, guidelines are few, and low levels of confidence persist.
2025 Postoperative Pain Management: Progress and Process
Latest Videos
All News
Advertisement
Advertisement
FDA authorized a reduced-risk claim for 20 ZYN nicotine pouches for adults who switch completely from cigarettes.
A 10-week video-based cognitive rehabilitation program improved patient-set goals in adults with long COVID cognitive symptoms.
Recent FDA actions include updates on COVID-19 prophylaxis, ADHD, PTSD neuromodulation, and pediatric psoriasis and psoriatic arthritis care.
FDA approved roflumilast (Zoryve) cream 0.3% for plaque psoriasis in children as young as age 2, expanding the once-daily steroid-free topical indication.
A deep learning ECG model identified a high-risk group with a 7.0% annual sudden cardiac death rate in a new study.
FDA approved risankizumab for children aged 6 years or older with moderate to severe plaque psoriasis or active psoriatic arthritis.
Centanafadine XR improved adult ADHD symptoms in a phase 3b trial of patients with comorbid generalized or social anxiety disorder.
SLEEP 2026: Ashesha Mechineni, MD, discusses what the emerging pharmacotherapy pipeline means for clinicians.
Survey finds 18 million women 45–64 overdue for cancer screening, led by colorectal gaps—bundled reminders could
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears First Generic Baloxavir for Influenza Treatment, Postexposure Prophylaxis
2
How Primary Care Can Close DKA Monitoring Gaps Before Hospitalization
3
Why DKA Detection Needs to Start Before the Emergency Department
4
FDA Clears OTC Adapalene-Benzoyl Peroxide Gel for Acne in Patients 12 and Older
5